Johnson & Johnson to start coronavirus vaccine human trials in September
The announcement was part of a $1 billion deal made with the US government to create the manufacturing capacity for 1 billion vaccine doses.
An employee of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany(photo credit: REUTERS/ANDREAS GEBERT)ByREUTERS
